ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
The role of tissue kallikrein 1 in hematopoietic stem cell transplant-associated thrombotic microangiopathy | Baylor College of Medicine / Sarah Sartain, MD | Innovation Grants | 2024 | Texas |
MYCN-induced molecular clock disruption and metabolic rewiring drive neuroblastoma | Baylor College of Medicine / Lingzhi Li, PhD | Young Investigator Grants | 2024 | Texas |
Development of allogeneic off-the-shelf gamma delta T cell product for pediatric AML | Baylor College of Medicine / Norihiro Watanabe, PhD | Innovation Grants | 2024 | Texas |
Capitalizing on functional genomics with targeted protein degradation in neuroblastoma | St. Jude Children’s Research Hospital / Ian Delahunty, PhD | Young Investigator Grants | 2024 | Tennessee |
Modifying CAR T cell epigenetic programs to improve therapy against aggressive pediatric brain tumors | St. Jude Children’s Research Hospital / Meghan Ward, PhD | Young Investigator Grants | 2024 | Tennessee |
Vaccine-boosted CAR T cell therapy for high risk neuroblastoma | Children’s Hospital of Philadelphia / Timothy Spear, MD/PhD | Young Investigator Grants | 2024 | Pennsylvania |
Therapeutic targeting of clonal hematopoiesis in RUNX1 mutant FPDMM | University of Pennsylvania / Robert Bowman, Ph.D. | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2024 | Pennsylvania |
Direct targeting of oncoprotein assembly using mimetic peptide interference | Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD | Innovation Grants | 2024 | New York |
Utilizing chromatin directed inhibitors to regulate gene expression in Ewing sarcoma for therapeutic benefit | University of North Carolina / Justin Sperlazza, MD/PhD | Young Investigator Grants | 2024 | North Carolina |
Unraveling GABAergic interneuron-like lineage in H3G34-mutant hemispheric high-grade gliomas: their impact on network formation and invasion | Dana-Farber Cancer Institute / Gustavo Alencastro Veiga Cruzeiro, PhD | Young Investigator Grants | 2024 | Massachusetts |